This dataset explores the impact of COVID-19 mitigation measures on opioid use disorder treatment in state correctional facilities, focusing on the accessibility of medication-related treatment and state-level interventions.

This dataset explores state laws affecting syringe service programs, which reduce HIV transmission and support opioid misuse prevention. It highlights legal barriers and opportunities for improved drug policy.

This article explores state laws from 2001 to 2022 on naloxone access for opioid overdose prevention, focusing on immunity protections, third-party prescribing, and pharmacist dispensing mechanisms.

This dataset examines how states used Medicaid waivers during COVID-19 to increase access to substance use disorder treatment, focusing on telehealth expansion and adjustments to Medicaid requirements.

This dataset examines how state laws increased access to buprenorphine and methadone medications for opioid use disorder during the COVID-19 pandemic, focusing on telehealth expansion and policy changes to improve treatment access.

This dataset reviews state laws on involuntary commitment for substance use, focusing on clinical assessments, judicial review, treatment authorization, and patient rights from 2018–2021.

This dataset explores state-specific commercial insurance and Medicaid coverage laws affecting access to medications for opioid use disorder treatment.

This dataset examines state licensure and scope of practice regulations that affect access to medications for opioid use disorder treatment across the U.S.

This essay examines Medicaid's critical role in the opioid epidemic, highlighting improved outcomes for those with coverage while addressing policy threats like work requirements and block grants.

This article examines the effectiveness of smoke-free policies in reducing tobacco use, secondhand smoke exposure, and related health risks, highlighting significant public health improvements.

This article explores a court decision on Safehouse, an overdose prevention site, highlighting its implications for drug policy aimed at minimizing harm from drugs and drug regulation.

This data explores state laws on tobacco pricing strategies, highlighting taxation and prevention measures to reduce consumption and improve public health through evidence-based policy.

This dataset examines laws and policies on Medication Assisted Treatment (MAT) for opioid use disorder in state correctional facilities, focusing on access to FDA-approved medications as of August 2019.

This dataset reviews Medicaid coverage of FDA-approved Medication Assisted Treatment (MAT) drugs, highlighting statutes, regulations, and preferred drug lists effective as of August 2019.

This article evaluates the effectiveness of workplace smoking bans in reducing smoking behaviors. A meta-analysis of 26 studies found that bans lead to decreased cigarette consumption and prevalence, with positive public health impacts.